Point of care blood eosinophil guided oral prednisolone for COPD exacerbations: a multi-centre double blind randomised controlled trial (The STARR2 trial)Sanjay Ramakrishnan, M Bafadhel, R E Russell et al.|Unknown|2022Cited by 8
S122 Oestrogen and ER-β: implications for COPDChristine Mwasuku, M Bafadhel, Jillian G. Baker et al.|Unknown|2025Cited by 1
S63 Eosinophilic inflammation at exacerbations of COPD is associated with less dynamic troponin rises in the 30 days post exacerbationPauline R.M. Dobson, Richard Russell, Wollaeger Ee et al.|Unknown|2024Cited by 0
S100 Relationship of cardiac biomarkers in COPD at stable state and exacerbationPauline R.M. Dobson, REK Russell, Wollaeger Ee et al.|Unknown|2025Cited by 0
P155 Determinants of dynamic troponin rise within 30 days of moderate COPD exacerbationPauline R.M. Dobson, REK Russell, Steven P. Cass et al.|Unknown|2025Cited by 0